Please ensure Javascript is enabled for purposes of website accessibility Century of biotech: capitalising on the biomedical revolution - Janus Henderson Investors

Century of biotech: capitalising on the biomedical revolution

Andy Acker, CFA

Andy Acker, CFA

Portfolio Manager


Daniel Lyons, PhD, CFA

Daniel Lyons, PhD, CFA

Portfolio Manager | Research Analyst


Agustin Mohedas, PhD

Agustin Mohedas, PhD

Portfolio Manager | Research Analyst


21 Apr 2022

Remarkable advances in biomedical research are leading to rapid growth and volatility in the biotechnology sector. An investment strategy rooted in deep analysis spanning public and private entities and using short sales to hedge against risk could help maximize return potential. 

Please follow the download link to access the full Biotech whitepaper.

Download